CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 87 filers reported holding CYTOSORBENTS CORP in Q4 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $97,000 | -27.1% | 12,150 | -10.0% | 0.04% | -23.2% |
| Q2 2020 | $133,000 | +27.9% | 13,500 | 0.0% | 0.06% | +21.7% |
| Q1 2020 | $104,000 | +100.0% | 13,500 | 0.0% | 0.05% | +142.1% |
| Q4 2019 | $52,000 | -22.4% | 13,500 | 0.0% | 0.02% | -29.6% |
| Q3 2019 | $67,000 | -24.7% | 13,500 | 0.0% | 0.03% | -32.5% |
| Q2 2019 | $89,000 | -16.0% | 13,500 | -4.3% | 0.04% | -42.0% |
| Q1 2019 | $106,000 | -11.7% | 14,108 | -4.0% | 0.07% | +19.0% |
| Q4 2018 | $120,000 | -31.8% | 14,700 | 0.0% | 0.06% | -38.3% |
| Q3 2018 | $176,000 | +40.8% | 14,700 | -16.7% | 0.09% | +64.9% |
| Q2 2018 | $125,000 | -50.0% | 17,650 | -50.0% | 0.06% | -23.0% |
| Q1 2018 | $250,000 | +242.5% | 35,300 | +234.6% | 0.07% | +117.6% |
| Q4 2017 | $73,000 | – | 10,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |